Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications

Journal of Pathology

Volumn 215, Issue 1, 2008, Pages 21-30

  De Jong, J ^a   Stoop, H ^a   Gillis, A J M ^a   Van Gurp, R J H L M ^a   Van De Geijn, G J M ^a   De Boer, M ^a   Hersmus, R ^a   Saunders, P T K ^b   Anderson, R A ^b   Oosterhuis, J W ^a   Looijenga, L H J ^a,c  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c NONE   (Netherlands)

Author keywords

Carcinoma in situ; Embryonal carcinoma; OCT3 4; POU5F1; Seminoma; SOX17; SOX2

Indexed keywords

MARKER; TRANSCRIPTION FACTOR SOX17; TRANSCRIPTION FACTOR SOX18;

ADOLESCENT; ADULT; ARTICLE; CARCINOMA IN SITU; DIAGNOSTIC TEST; EMBRYO; EMBRYONAL CARCINOMA; FETUS; GENE EXPRESSION PROFILING; GENOME; GERM CELL; GERM CELL TUMOR; GONAD; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINOMA; STEM CELL; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CARCINOMA IN SITU; CELL LINE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GERM CELLS; GERMINOMA; HIGH MOBILITY GROUP PROTEINS; HMGB PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OCTAMER TRANSCRIPTION FACTOR-3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEMINOMA; STEM CELLS; TESTICULAR NEOPLASMS; TESTIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 42949173880     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2332     Document Type: Article

References (67)

1. Grosschedl R, Giese K, Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 1994;10:94-100.
2. Marshall Graves JA. Sex chromosomes and sex determination in weird mammals. Cytogenet Genome Res 2002;96:161-168.
3. Pevny LH, Lovell-Badge R. Sox genes find their feet. Curr Opin Genet Dev 1997;7:338-344.
4. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 1999;27:1409-1420.
5. Dailey L, Basilico C. Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J Cell Physiol 2001;186:315-328.
6. Kamachi Y, Uchikawa M, Kondoh H. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 2000;16:182-187.
7. Veenstra GJ, van der Vliet PC, Destree OH. POU domain transcription factors in embryonic development. Mol Biol Rep 1997;24:139-155.
8. Phillips K, Luisi B. The virtuoso of versatility: POU proteins that flex to fit. J Mol Biol 2000;302:1023-1039.
9. Donner AL, Episkopou V, Maas RL. Sox2 and Pou2f1 interact to control lens and olfactory placode development. Dev Biol 2007;303:784-799.
10. Ghislain J, Charnay P. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep 2006;7:52-58.
11. Kuhlbrodt K, Herbarth B, Sock E, Enderich J, Hermans-Borgmeyer I, Wegner M. Cooperative function of POU proteins and SOX proteins in glial cells. J Biol Chem 1998;273:16050-16057.
12. Remenyi A, Lins K, Nissen LJ, Reinbold R, Scholer HR, Wilmanns M. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev 2003;17:2048-2059.
13. Chew JL, Loh YH, Zhang W, Chen X, Tam WL, Yeap LS, et al. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol 2005;25:6031-6046.
14. Okumura-Nakanishi S, Saito M, Niwa H, Ishikawa F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem 2005;280:5307-5317.
15. Catena R, Tiveron C, Ronchi A, Porta S, Ferri A, Tatangelo L, et al. Conserved POU binding DNA sites in the Sox2 upstream enhancer regulate gene expression in embryonic and neural stem cells. J Biol Chem 2004;279:41846-41857.
16. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-368.
17. Rao S, Orkin SH. Unraveling the transcriptional network controlling ES cell pluripotency. Genome Biol 2006;7:230.
18. de Jong J, Looijenga LH. Stem cell marker OCT3/4 in tumor biology and germ cell tumor diagnostics: history and future. Crit Rev Oncog 2006;12:171-203.
19. Pan G, Li J, Zhou Y, Zheng H, Pei D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J 2006;20:1730-1732.
20. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genet 2000;24:372-376.
21. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nature Cell Biol 2007;9:625-635.
22. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.
23. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, Chen X, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genet 2006;38:431-440.
24. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003;17:126-140.
25. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW, et al. A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990;345:686-692.
26. Molyneaux K, Wylie C. Primordial germ cell migration. Int J Dev Biol 2004;48:537-544.
27. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379- 391.
28. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumours in a broader perspective. Nature Rev Cancer 2005;5:210-222.
29. Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 2005;36:512-521.
30. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006;27:468-484.
31. Honecker F, Stoop H, Mayer F, Bokemeyer C, Castrillon DH, Lau YF, et al. Germ cell lineage differentiation in non-seminomatous germ cell tumours. J Pathol 2006;208:395-400.
32. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003;63:2244-2250.
33. de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, van Esser JWJ, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 2005;206:242-249.
34. Cheng L, Sung MT, Cossu-Rocca P, Jones T, Maclennan G, De Jong J, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2006;211:1-9.
35. Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW. OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol 2004;28:1341-1346.
36. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004;28:935-940.
37. Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005;104:2092-2098.
38. Looijenga LH, Hersmus R, Gillis AJ, Pfundt R, Stoop HJ, van Gurp RJ, et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 2006;66:290-302.
39. Berney DM, Lee A, Shamash J, Oliver RT. The association between intratubular seminoma and invasive germ cell tumors. Hum Pathol 2006;37:458-461.
40. Skotheim RI, Lind GE, Monni O, Nesland JM, Abeler VM, Fossa SD, et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 2005;65:5588-5598.
41. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006;66:820-827.
42. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, et al. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 2006;26:9722-9735.
43. Kanai Y, Kanai-Azuma M, Noce T, Saido TC, Shiroishi T, Hayashi Y, et al. Identification of two Sox17 messenger RNA isoforms, with and without the high mobility group box region, and their differential expression in mouse spermatogenesis. J Cell Biol 1996;133:667-681.
44. Wang R, Cheng H, Xia L, Guo Y, Huang X, Zhou R. Molecular cloning and expression of Sox17 in gonads during sex reversal in the rice field eel, a teleost fish with a characteristic of natural sex transformation. Biochem Biophys Res Commun 2003;303:452-457.
45. Kim I, Saunders TL, Morisson SJ. Sox17 dependence distinguishes the transcriptional regulation of fetal from adult hematopoietic stem cells. Cell 2007;130:470-483.
46. Robinson LLL, Gaskell TL, Saunders PTK, Anderson RA. Germ cell specific expression of c-kit in the human fetal gonad. Mol Hum Reprod 2001;7:845-852.
47. de Jong J, Stoop H, Gillis AJM, Hersmus R, Van Gurp RJHLM, Van de Geijn G-JM, et al. Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 2007;47:185-196.
48. Fogh J. Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors. Natl Cancer Inst Monogr 1978;49:5-9.
49. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, et al. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 1984;50:147-162.
50. Wang N, Trend B, Bronson DL, Fraley EE. Nonrandom abnormalities in chromosome 1 in human testicular cancers. Cancer Res 1980;40:796- 802.
51. Mavilio F, Simeone A, Boncinelli E, Andrews PW. Activation of four homeobox gene clusters in human embryonal carcinoma cells induced to differentiate by retinoic acid. Differentiation 1988;37:73-79.
52. Teshima S, Shimosato Y, Hirohashi S, Tome Y, Hayashi I, Kanazawa H, et al. Four new human germ cell tumor cell lines. Lab Invest 1988;59:328-336.
53. Burger H, Nooter K, Boersma AW, van Wingerden KE, Looijenga LH, Jochemsen AG, et al. Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines. Int J Cancer 1999;81:620-628.
54. de Jong J, Stoop H, Gillis AJM, Van Gurp RJHLM, Van Drunen E, Beverloo HB, et al. JKT-1 is not a human seminoma cell line. Int J Androl 2007;30:350-365.
55. Looijenga LHJ, Gillis AJM, Stoop H, Hersmus R, Oosterhuis JW. Chromosomes and expression in human testicular germ cell tumors: insight in origin and pathogenesis. N Y Acad Sci 2008;1120:187-214.
56. Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol 2007;31:836-845.
57. Phi JH, Park SH, Paek SH, Kim SK, Lee YJ, Park CK, et al. Expression of Sox2 in mature and immature teratomas of central nervous system. Mod Pathol 2007;20:742-748.
58. Wood HB, Episkopou V. Comparative expression of the mouse Sox1, Sox2 and Sox3 genes from pre-gastrulation to early somite stages. Mech Dev 1999;86:197-201.
59. Kiernan AE, Pelling AL, Leung KK, Tang AS, Bell DM, Tease C, et al. Sox2 is required for sensory organ development in the mammalian inner ear. Nature 2005;434:1031-1035.
60. Bani-Yaghoub M, Tremblay RG, Lei JX, Zhang D, Zurakowski B, Sandhu JK, et al. Role of Sox2 in the development of the mouse neocortex. Dev Biol 2006;295:52-66.
61. Collignon J, Sockanathan S, Hacker A, Cohen-Tannoudji M, Norris D, Rastan S, et al. A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. Development 1996;122:509-520.
62. Payen E, Pailhoux E, Gianquinto L, Hayes H, Le Pennec N, Bezard J, et al. The ovine SOX2 gene: sequence, chromosomal localization and gonadal expression. Gene 1997;189:143-147.
63. Western P, Maldonado-Saldivia J, van den Bergen J, Hajkova P, Saitou M, Barton S, et al. Analysis of Esg1 expression in pluripotent cells and the germline reveals similarities with Oct4 and Sox2 and differences between human pluripotent cell lines. Stem Cells 2005;23:1436-1442.
64. Yabuta Y, Kurimoto K, Ohinata Y, Seki Y, Saitou M. Gene expression dynamics during germline specification in mice identified by quantitative single-cell gene expression profiling. Biol Reprod 2006;75:705- 716.
65. Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, Kurohmaru M, et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 2002;129:2367-2379.
66. Takao Y, Yokota T, Koide H. Beta-catenin up-regulates Nanog expression through interaction with Oct-3/4 in embryonic stem cells. Biochem Biophys Res Commun 2006;353:699-705.
67. Sinner D, Rankin S, Lee M, Zorn AM. Sox17 and beta-catenin cooperate to regulate the transcription of endodermal genes. Development 2004;131:3069-3080.